InsiderDB

Lobbying disclosures · Lobbying report

ABBV: third_quarter 2026 lobbying report

Education around data privacy. Education about the drug approval process at FDA.

Follow ABBV
Became public
Oct 20, 2026, 3:29 PM EDT
Event / period date
Not stated
Collected
Nov 9, 2026, 9:38 AM EST

Why this is connected

Exact legal-name match: AbbVie Inc. (https://www.sec.gov/Archives/edgar/data/1551152/).

Reported lobbying amounts

Income: $50,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/6285ff09-e0af-4524-ab0d-dd3ed01b087e/","filing_uuid":"6285ff09-e0af-4524-ab0d-dd3ed01b087e","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/6285ff09-e0af-4524-ab0d-dd3ed01b087e/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Darren Willcox","dt_posted":"2026-10-20T15:29:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 Pennsylvania Avenue, NW","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400605842,"url":"https://lda.gov/api/v1/registrants/400605842/","house_registrant_id":null,"name":"W STRATEGIES, LLC","description":"Government Affairs Consulting Firm.","address_1":"1455 Pennsylvania Avenue, NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DARREN WILLCOX","contact_telephone":"+1 202-494-6268","dt_updated":"2026-07-30T12:17:37.753365-04:00"},"client":{"id":193500,"url":"https://lda.gov/api/v1/clients/193500/","client_id":191,"name":"ABBVIE INC.","general_description":"Biopharmaceutical company.","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Education around data privacy. Education about the drug approval process at FDA.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51473,"prefix":null,"prefix_display":null,"first_name":"DARREN","nickname":null,"middle_name":null,"last_name":"WILLCOX","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Price change after we could observe it

+0.37% ABBV

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in ABBV

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.